These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
559 related items for PubMed ID: 24461094
21. Clinicopathological analysis of 46 cases with CD4+ and/or CD56+ immature haematolymphoid malignancy: reappraisal of blastic plasmacytoid dendritic cell and related neoplasms. Suzuki Y, Kato S, Kohno K, Satou A, Eladl AE, Asano N, Kono M, Kato Y, Taniwaki M, Akiyama M, Nakamura S. Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410 [Abstract] [Full Text] [Related]
22. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases]. Machet L, De Muret A, Wiezberka E, Bernez A, Abdallah-Lotf M, Linassier C, Petrella T. Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384 [Abstract] [Full Text] [Related]
23. [Clinical Characteristics of CD4-CD56+ Blastic Plasmacytoid Dendritic Cell Neoplasm]. He HS, Wei YF, Ji XY, Xu YH, Yang YQ, Jin XK. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871 [Abstract] [Full Text] [Related]
25. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm). Su O, Onsun N, Demirkesen C, Aydin Y, Pirmit S, Gereli M. Dermatol Online J; 2010 Apr 15; 16(4):8. PubMed ID: 20409415 [Abstract] [Full Text] [Related]
26. Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature. Ruggiero A, Maurizi P, Larocca LM, Arlotta A, Riccardi R. Haematologica; 2006 Dec 15; 91(12 Suppl):ECR48. PubMed ID: 17194654 [Abstract] [Full Text] [Related]
27. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study]. Sang W, Wang CF, Cheng YF, Liu X, Li XX, Gulinar A, Li JZ, Zhang W. Zhonghua Bing Li Xue Za Zhi; 2012 May 15; 41(5):326-30. PubMed ID: 22883672 [Abstract] [Full Text] [Related]
28. Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea. Kim HS, Kim HJ, Kim SH, Choi JY, Ko YH, Kim WS, Jung CW, Kim SJ. Korean J Intern Med; 2017 Sep 15; 32(5):890-899. PubMed ID: 28870016 [Abstract] [Full Text] [Related]
29. Blastic Plasmacytoid Dendritic Cell Neoplasia: A Single Center Experience. Demiröz AS, Demirkesen C, Salihoğlu A, Tüzüner N. Turk J Haematol; 2020 Feb 20; 37(1):48-52. PubMed ID: 31752482 [Abstract] [Full Text] [Related]
30. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Herling M, Jones D. Am J Clin Pathol; 2007 May 20; 127(5):687-700. PubMed ID: 17439829 [Abstract] [Full Text] [Related]
31. Blastic plasmacytoid dendritic cell neoplasm. Lim D, Goodman H, Rademaker M, Lamont D, Yung A. Australas J Dermatol; 2013 May 20; 54(2):e43-5. PubMed ID: 23582004 [Abstract] [Full Text] [Related]
32. [Blastic plasmacytoid dendritic cell neoplasm: A clinico-pathological retrospective analysis of thirteen cases]. Nong L, Wang W, Liang L, Li D, Li X, Li T. Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr 18; 55(2):308-314. PubMed ID: 37042142 [Abstract] [Full Text] [Related]
33. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. Shumilov E, Mazzeo P, Ghandili S, Künstner A, Weidemann S, Banz Y, Ströbel P, Pollak M, Kolloch L, Beltraminelli H, Kerkhoff A, Mikesch JH, Schliemann C, Haase D, Wulf G, Legros M, Lenz G, Feldmeyer L, Pabst T, Witte H, Gebauer N, Bacher U. Ann Hematol; 2024 May 18; 103(5):1587-1599. PubMed ID: 38194088 [Abstract] [Full Text] [Related]
34. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Urosevic M, Conrad C, Kamarashev J, Asagoe K, Cozzio A, Burg G, Dummer R. Hum Pathol; 2005 Sep 18; 36(9):1020-4. PubMed ID: 16153467 [Abstract] [Full Text] [Related]
35. Cutaneous CD4+ CD56+ hematologic malignancies. Magro CM, Porcu P, Schaefer J, Erter JW, Furman RR, Shitabata PK, Crowson AN. J Am Acad Dermatol; 2010 Aug 18; 63(2):292-308. PubMed ID: 20541283 [Abstract] [Full Text] [Related]
36. Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia. Bétrian S, Guenounou S, Luquet I, Demur C, Huynh A, Ysebaert L, Recher C, Huguet F. Hematol Oncol; 2017 Jun 18; 35(2):252-255. PubMed ID: 28620927 [Abstract] [Full Text] [Related]
37. Blastic plasmacytoid dendritic cell neoplasm: cytopathologic findings. Zheng G, Schmieg J, Guan H, Ali SZ. Acta Cytol; 2012 Jun 18; 56(2):204-8. PubMed ID: 22378086 [Abstract] [Full Text] [Related]
38. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review. Ding Y, Yang J, Lindsey K. Diagn Cytopathol; 2021 Feb 18; 49(2):E80-E83. PubMed ID: 32852895 [Abstract] [Full Text] [Related]
39. Leukemic manifestation of blastic plasmacytoid dendritic cell neoplasm lacking skin lesion : a borderline case between acute monocytic leukemia. Takiuchi Y, Maruoka H, Aoki K, Kato A, Ono Y, Nagano S, Arima H, Inoue D, Mori M, Tabata S, Yanagita S, Matsushita A, Nishio M, Imai Y, Imai Y, Ito K, Fujita H, Kadowaki N, Ishikawa T, Takahashi T. J Clin Exp Hematop; 2012 Feb 18; 52(2):107-11. PubMed ID: 23037626 [Abstract] [Full Text] [Related]
40. Sustained complete remission of a limited-stage blastic plasmacytoid dendritic cell neoplasm followed by a simultaneous combination of low-dose DeVIC therapy and radiation therapy: a case report and review of the literature. Sugimoto KJ, Shimada A, Yamaguchi N, Imai H, Wakabayashi M, Sekiguchi Y, Izumi H, Ota Y, Komatsu N, Noguchi M. Int J Clin Exp Pathol; 2013 Feb 18; 6(11):2603-8. PubMed ID: 24228127 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]